Roche, SQZ to develop engineered B cells for cancer

Roche (SIX:ROG; OTCQX:RHHBY) partnered with SQZ Biotechnologies Co. (Boston, Mass.) to develop engineered B cells for oncology indications using SQZ's CellSqueeze platform.

The CellSqueeze platform is a microfluidics-based system that constrains cells in order to open transient pores in the cell membrane, allowing delivery of bioactive materials into the cells (see SciBX: Science Business eXchange, Nov. 13, 2014). ...